Evidence map›Paper›PMID 11285310›Full record

ArticleThe Journal of clinical investigation2001

Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.

A M Waaga, M Gasser, J E Kist-van Holthe, N Najafian, A Müller, J P Vella, K L Womer, A Chandraker, S J Khoury, M H Sayegh

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  9. Article
  10. Article
  11. Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.International journal of clinical and experimental pathology · 2014
    Article
  12. Review
  13. Role of IL-10 in the progression of kidney disease.World journal of transplantation · 2013
    Review
  14. Article
  15. Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected].American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2013
    Article
  16. The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Review
  17. Article
  18. IL-6 promotes cardiac graft rejection mediated by CD4+ cells.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
  19. Article
  20. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

A M WaagaLaboratory of Immunogenetics and Transplantation, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
M Gasser
J E Kist-van Holthe
N Najafian
A Müller
J P Vella
K L Womer
A Chandraker
S J Khoury
M H Sayegh
Brigham and Women's Hospital · USHarvard University Press · USBoston Children's Hospital · USHarvard University · US

Funding

INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDESR01AI034965 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SAYEGH, MOHAMED H · 1999 to 2003
$1.3M
IMMUNE MECHANISMS OF CHRONIC ALLOGRAFT REJECTIONR01AI040629 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CARPENTER, CHARLES B · 1997 to 2000
$353k
NIAID NIH HHS AI 40629NIAID NIH HHS R01 AI034965NIAID NIH HHS R01 AI34965PHS HHS IZKF 01 KS 9603
6 · The paper itself

Abstract

We studied T-cell clones generated from grafts of rejecting and tolerant animals and investigated the regulatory function of Th2 clones in vitro and in vivo. To prevent allograft rejection, we treated LEW strain recipient rats of WF strain kidney grafts with CTLA4Ig to block CD28-B7 costimulation. We then isolated epitope-specific T-cell clones from the engrafted tissue, using a donor-derived immunodominant class II MHC allopeptide presented by recipient antigen-presenting cells. Acutely rejected tissue from untreated animals yielded self-restricted, allopeptide-specific T-cell clones that produced IFN-gamma, whereas clones from tolerant animals produced IL-4 and IL-10. Adoptive transfer into naive recipients of Th1 clones, but not Th2 clones, induced alloantigen-specific delayed-type hypersensitivity (DTH) responses. In addition, Th2 clones suppressed DTH responses mediated by Th1 clones in vivo and blocked Th1 cell proliferation and IFN-gamma production in vitro. A pilot human study showed that HLA-DR allopeptide-specific T-cell clones generated from patients with chronic rejection secrete Th1 cytokines, whereas those from patients with stable graft function produce Th2 cytokines in response to donor-specific HLA-DR allopeptides. We suggest that self-restricted alloantigen-specific Th2 clones may regulate the alloimmune responses and promote long-term allograft survival and tolerance.

Indexed as

AnimalsCell LineClone CellsGraft RejectionHistocompatibility AntigensHistocompatibility Antigens Class IIHumansImmunophenotypingKidney TransplantationMalePeptidesRatsRats, Inbred LewRats, Inbred WFTh1 CellsTh2 CellsHistocompatibility AntigensHistocompatibility Antigens Class IIhistocompatibility antigens RT, ratPeptides

Identifiers

PMID11285310
PMCPMC199572
OpenAlexW2120679488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.